Literature DB >> 1389107

Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.

T N Ledger1, B K Sil, M R Wills, G Lewis, R M Kinney, A D Jennings, J R Stephenson, A D Barrett.   

Abstract

Three different virus strains (17D-204, 17DD and the French neurotropic vaccine) have been used as live attenuated yellow fever (YF) vaccines and are manufactured in different centres around the world. The envelope proteins of these vaccine viruses were examined and compared using mouse monoclonal antibodies (MAbs) in haemagglutination inhibition (HAI) and neutralization (N) tests. The epitopes eliciting HAI and/or N were found to vary depending on the virus examined. Such variation was also found between vaccine viruses of the same strain manufactured in different centres. These data were confirmed by the use of mouse polyclonal antisera. On the basis of the MAb results in HAI tests a dendrogram of the similarity coefficients between the viruses was constructed and showed that the viruses could be placed into three major groups. Thus, it is concluded that YF vaccines manufactured in different centres are antigenically distinct as recognized by the mouse immune system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389107     DOI: 10.1016/s1045-1056(05)80059-4

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  3 in total

1.  Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.

Authors:  Matthew T Aliota; Dawn M Dudley; Christina M Newman; Emma L Mohr; Dane D Gellerup; Meghan E Breitbach; Connor R Buechler; Mustafa N Rasheed; Mariel S Mohns; Andrea M Weiler; Gabrielle L Barry; Kim L Weisgrau; Josh A Eudailey; Eva G Rakasz; Logan J Vosler; Jennifer Post; Saverio Capuano; Thaddeus G Golos; Sallie R Permar; Jorge E Osorio; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  PLoS Negl Trop Dis       Date:  2016-12-02

Review 2.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

3.  Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.

Authors:  Emily H Davis; Binbin Wang; Mellodee White; Yan-Jang S Huang; Vanessa V Sarathy; Tian Wang; Nigel Bourne; Stephen Higgs; Alan D T Barrett
Journal:  NPJ Vaccines       Date:  2022-03-23       Impact factor: 9.399

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.